Related Experiment Video
Updated: Jun 12, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication
Christopher M Owens1, Christina Mawhinney, Jill M Grenier
1CombinatoRx, Incorporated, Cambridge, MA 02142, USA.
Molecular Systems Biology
|June 10, 2010
Summary
Exploring Hepatitis C antiviral therapies, this study reveals how sterol metabolism and protein prenylation pathways interact. Targeting downstream sterol enzymes offers synergistic inhibition of viral replication with reduced host toxicity.
Area of Science:
- Virology
- Biochemistry
- Pharmacology
Background:
- Hepatitis C virus (HCV) replication is indirectly influenced by host sterol metabolism and protein prenylation.
- Previous attempts to inhibit the sterol pathway with statins showed inconsistent clinical outcomes.
- Understanding the interplay between these pathways is crucial for developing effective HCV therapies.
Purpose of the Study:
- To investigate the combined effects of targeting sterol and protein prenylation pathways on HCV replication using a chemical genetic approach.
- To identify novel therapeutic targets and understand pathway interactions influencing viral replication.
- To discover synergistic drug combinations with improved selectivity for viral inhibition over host toxicity.
Main Methods:
- Utilized a combination chemical genetic study in a Hepatitis C virus replicon assay.
- Systematically analyzed the effects of shifting targets downstream along the sterol pathway.
- Evaluated antiviral effects and host toxicity of combined pathway inhibition.
Main Results:
- HCV replication is significantly modulated by sterol pathway regulation.
- A transition from antagonistic to synergistic antiviral effects was observed as targets moved downstream.
- Combinations targeting downstream sterol pathway enzymes demonstrated robust, selective synergistic inhibition of HCV replication.
- Identified novel synergies that selectively inhibit viral replication while sparing host cells.
Conclusions:
- Combination chemical genetics can elucidate critical pathway connections relevant to viral replication.
- Sterol pathway regulation presents challenges but also opportunities for HCV therapy.
- Targeting downstream sterol pathway enzymes offers a promising strategy for developing HCV treatments with an enhanced therapeutic window.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.